EpiQMAx has been listed as an "Invest" company by the German Ministry of Economics
By investing on EpiQMAx, business angels could get back from the state a maximum of 20% their investment. More here.
EpiQMAx passes to the second phase of the Munich Business Plan contest
Our business idea keeps on convincing juries and the general public. In the 2019 competition of the Munich Business Plan, EpiQMAx was awarded a prize beside other 9 teams.
EpiQMAx GmbH is officially founded
We are happy to announce that as from October 19th 2018, EpiQMAx starts its bussines activity as a private Limited Liability Company.
EpiQMAx obtains funds from the EXIST Program
The EXIST scholarship for start-up founders is helping EpiQMAx in the implementation of its business idea and the realization of milestones important for our service.
EpiQMAx wins prize at MIT:FUTURA
Moritz presented our business idea at the MIT:FUTURA digital event in Berlin in June 2018. EpiQMAx was prized with the first place for its innovative business model and digital transformation strategy.
EpiQMAx is developing a KIT to measure protein modifications
We are developing a KIT to measure histone modifcations easily, reproducibly and fast. The first prototypes showed a greater yield and low losses of sample material. This means that we can achieve good levels of detection and quantification with low sample inputs. We aim now for a protective right and will work together with other experts in the field of proteomic KITs to achieve this.
EpiQMAx obtains funds from the FLÜGGE Program
For the month of September 2018, EpiQMAx will be supported by Flügge for, among other aspects, the development of a laboratory KIT.